SCHEMBL30764753

SCHEMBL30764753

O=C(Cc1ccc(Cl)cc1)N1CC2(CN(Cc3ccc(C(F)(F)F)o3)C2)C1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.46
GPR183 P32249 6/20 0.39
KMT2A Q03164 2/20 0.38
MEN1 O00255 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
GFER P55789 1/20 0.37
ATM Q13315 1/20 0.37
ME2 P23368 1/20 0.37
ME1 P48163 1/20 0.37
ME3 Q16798 1/20 0.37
CNR1 P21554 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM3 P20309 1/20 0.36
PLA2G7 Q13093 1/20 0.35
MGLL Q99685 1/20 0.35
ABHD6 Q9BV23 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30764707 0.77 HSD11B1 (0.55) HSD11B1GPR183KMT2AMEN1CYP2C9
SCHEMBL30764735 0.75 HSD11B1 (0.51) HSD11B1GPR183KMT2AMEN1GFER
SCHEMBL30764705 0.73 EPHX2 (0.45) HSD11B1GPR183KMT2AMEN1CYP2C19
SCHEMBL30764715 0.73 HSD11B1 (0.51) HSD11B1GPR183KMT2AMEN1CYP2C9
SCHEMBL30764755 0.71 GAA (0.54) HSD11B1KMT2AMEN1
SCHEMBL30764763 0.71 HSD11B1 (0.46) HSD11B1GPR183KMT2ACYP2C9CYP2C19
SCHEMBL30764734 0.71 KMT2A (0.54) HSD11B1GPR183KMT2AMEN1GFER
SCHEMBL30764758 0.70 KDM4E (0.59) HSD11B1GPR183KMT2AMEN1GFER
SCHEMBL27253355 0.70 HSD11B1 (0.62) HSD11B1GPR183KMT2AMEN1CYP2C9
SCHEMBL30764713 0.70 HSD11B1 (0.47) HSD11B1GPR183KMT2AMEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4568968-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS Remynd N.V. (BE) 2025-06-18 EP disclosed
WO-2024033479-A1 (AZA)SPIROHEPTANE DERIVATIVES FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS REMYND N.V. (BE) 2024-02-15 WO disclosed